Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol.

× No keyword cloud information.

15 in total

1. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.

Authors: Cristina Pérez; Julia González-Rincón; Arantza Onaindia; Carmen Almaráz; Nuria García-Díaz; Helena Pisonero; Soraya Curiel-Olmo; Sagrario Gómez; Laura Cereceda; Rebeca Madureira; Mercedes Hospital; Dolores Suárez-Massa; José L Rodriguez-Peralto; Concepción Postigo; Alicia Leon-Castillo; Carmen González-Vela; Nerea Martinez; Pablo Ortiz-Romero; Margarita Sánchez-Beato; Miguel Á Piris; José P Vaqué
Journal: Haematologica Date: 2015-08-20 Impact factor: 9.941

2. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b.

Authors: Zhen Quan; Yunfeng He; Chunli Luo; Yang Xia; Yan Zhao; Nanjing Liu; Xiaohou Wu
Journal: Cell Signal Date: 2017-01-16 Impact factor: 4.315

3. Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma.

Authors: Jianqiang Wu; Gary S Wood
Journal: Arch Dermatol Date: 2010-12-20

Review 4. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.

Authors: Rein Willemze; Lorenzo Cerroni; Werner Kempf; Emilio Berti; Fabio Facchetti; Steven H Swerdlow; Elaine S Jaffe
Journal: Blood Date: 2019-01-11 Impact factor: 22.113

5. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes.

Authors: Qian Zhang; Hong Y Wang; Anders Woetmann; Puthiyaveettil N Raghunath; Niels Odum; Mariusz A Wasik
Journal: Blood Date: 2006-08-01 Impact factor: 22.113

6. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.

Authors: V H Sommer; O J Clemmensen; O Nielsen; M Wasik; P Lovato; C Brender; K W Eriksen; A Woetmann; C G Kaestel; M H Nissen; C Ropke; S Skov; N Ødum
Journal: Leukemia Date: 2004-07 Impact factor: 11.528

7. Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3.

Authors: Maupali Dasgupta; Hamiyet Unal; Belinda Willard; Jinbo Yang; Sadashiva S Karnik; George R Stark
Journal: J Biol Chem Date: 2014-09-12 Impact factor: 5.157

8. The Janus kinase 2 inhibitor fedratinib inhibits thiamine uptake: a putative mechanism for the onset of Wernicke's encephalopathy.

Authors: Qiang Zhang; Yan Zhang; Sharon Diamond; Jason Boer; Jennifer J Harris; Yu Li; Mark Rupar; Elham Behshad; Christine Gardiner; Paul Collier; Phillip Liu; Timothy Burn; Richard Wynn; Gregory Hollis; Swamy Yeleswaram
Journal: Drug Metab Dispos Date: 2014-07-25 Impact factor: 3.922

9. Methotrexate Is a JAK/STAT Pathway Inhibitor.

Authors: Sally Thomas; Katherine H Fisher; John A Snowden; Sarah J Danson; Stephen Brown; Martin P Zeidler
Journal: PLoS One Date: 2015-07-01 Impact factor: 3.240

Review 10. Epigenetic Regulatory Mechanisms Induced by Resveratrol.

Authors: Guilherme Felipe Santos Fernandes; Gabriel Dalio Bernardes Silva; Aline Renata Pavan; Diego Eidy Chiba; Chung Man Chin; Jean Leandro Dos Santos
Journal: Nutrients Date: 2017-11-01 Impact factor: 5.717

1 in total

Review 1. Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas.

Authors: Karol Kołkowski; Magdalena Trzeciak; Małgorzata Sokołowska-Wojdyło
Journal: Int J Mol Sci Date: 2021-12-13 Impact factor: 5.923

1 in total